Niaspan Er
- Find
- Manage
- Resources
A study has found that niacin-based Niaspan was more effective than Crestor or Zocor at reducing levels of triglycerides and certain types of LDL (bad) cholesterol, as well as at increasing HDL (good) cholesterol. The study, which also included Lipitor, was funded by Kos Pharmaceuticals, maker of Niaspan.
Read moreMore information on "Niaspan Er"
From Our Experts
Hypertriglyceridemia: Drug Treatment
As mentioned in my previous article, non pharmacological treatment for high triglyceride (TG) levels can be quite effective with diet and... Read more »
Niacin – Statin Study Stopped Early
The National Institutes of Health stopped a clinical trial studying a blood lipid treatment 18 months early. The study found that adding... Read more »
Niacin: Myths and Facts
For a simple, available treatment that can dramatically reduce risk for heart attack, niacin has suffered more than its share of knocks,... Read more »
HDL Cholesterol May Help Protect Against Alzheimer's Disease
I recently had my annual physical, complete with blood tests. My doctor sent me the results and there’s one that I’m extremely happy to... Read more »
So, How Many Pills Do YOU Take?
Talk about getting old! Each and every day I take 14 different drugs and supplements for a total of 25 pills to fight my heart disease.... Read more »
From Our Sources
Cholesterol drug Niaspan may soon have "low flush" formula
Kos Pharmaceuticals has asked the Food and Drug Administration for approval of a new form of its cholesterol medicine Niaspan. The new caplet is... Read more »
Don't cut bad cholesterol, increase the good
A newly approved drug, Niaspan, increases good cholesterol levels. This may be the next wave in the fight against heart disease, say researchers. Read more »
New combo cholesterol med heads to the FDA
Drugmaker Abbott Laboratories has filed an application with the Food and Drug Administration for Simcor. Simcor is a new cholesterol med that... Read more »
Questions raised about Zetia in new study
A recent clinical trial on the bad cholesterol-lowering drug Zetia was stopped early after scientists found that a combination of this drug and a... Read more »
FDA approves combo cholesterol med Simcor
The U.S. Food and Drug Administration has approved Simcor, a combination drug designed to lower levels of bad cholesterol and triglycerides and raise... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
